All Type of News
Drugs landed on large hospitals at the end of the year
Which were the lucky drugs that went cross the door of therapeutics committees at university hospitals on the last December in 2015?
On the 31st, Medipana News analyzed the list of pharmaceutical products which passe...
A series of products introduced from multinational companies will create upheaval in the pharmaceutical industry
As pharmaceutical products introduced by domestic companies from multinational one have started to be expired in agreement, an upheaval in the industry is expected.
In order to overcome uncertainty which comes along ...
Despite clearing the cardiovascular dishonor, Avandia will be voluntarily withdrawn
Avandia(rosiglitazone), a thiazolidinediones(TZD) diabetes drug, was able to avoid the issue of having cardiovascular side effects, but decided to withdraw the domestic market, though.
It seems very contrary to other...
It’s been 10 years for Forsteo without insurance benefit
Will the unfortunate osteoporosis treatment, ‘Forsteo(teriparatide)’ succeed in getting the health insurance benefit?
Since Lilly, a supplier of Forsteo, has taken the re-deliberation process, the government is curre...
Rapid performance increase of RSA drugs requiring system modification
While the industry has had continuous issues about effectiveness of the Risk Sharing Agreement(RSA) System, drugs agreed to the system were observed to be increased in sales.
In an objective perspective about the agg...
35% of pharmaceutical R&D expenses are invested into personnel expenses
It was observed the ratio of R&D expenses to personnel expenses, when developing a new drug, is about 35% on average.
According to the aggregation result of the R&D/personnel expense ratio of 40 listed companies by t...
MSIP decides to support KRW 195 billion for biotechnology and medical technology development business
On the 28th, the Ministry of Science, ICT and Future Planning(MSIP) revealed the biotechnology and medical technology development business plans at the ‘Joint Briefings for the 2016 Governmental R&D Business.’
The MS...
‘Temporary supply suspension’ due to shortage of GSK’s ‘DTaP’ and ‘DTaP-IPV’ vaccinesDomestic supply of GSK’s ‘Infanrix’ and ‘Infanrix-IPV,’ DTaP(diphtheria, tetanus, pertussis) and DTaP-IPV(diphtheria, tetanus, pertussis, polio) vaccines used initially for infa...
|
First domestically-manufactured cholera vaccine acquiring WHO PQ license
On the 23rd, the Ministry of Food and Drug Safety(Minister Seung-hee Kim, MFDS) announced ‘Euvichol,’ a cholera vaccine that are being domestically manufactured, acquired the WHO’s requalification(PQ) license for the ...
Superiority of domestic products in the domestic blood glucose monitoring system market
The size of the domestic blood glucose monitoring system market was observed to grow more than 16% for the past 5 years. In the domestic market, particularly, domestic products were used more than foreign ones.
Accor...
